DYSTONIA MEDICAL RESEARCH FOUNDATION
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$6,422,430
Investments
72%
Cash & Equivalents
23%
Other Assets
3%
Receivables (Non-Related)
1%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Prepaid Expenses
0%
Liabilities in 2024 (Year End)
$1,298,142
Custodial & Escrow Liabilities
39%
Grants Payable
38%
Other Liabilities
16%
Payables & Accruals
7%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$1,036,163
$1,480,378
+43%
Receivables (Non-Related)
$529,047
$84,931
-84%
Related-Party Receivables
$0
$0
-
Inventories
$0
$0
-
Prepaid Expenses
$0
$0
-
Investments
$4,628,936
$4,643,298
+0%
Property, Plant, & Equipment (net)
$8,263
$7,953
-4%
Other Assets
$241,285
$205,870
-15%
Total Assets
$6,443,694
$6,422,430
0%
Liabilities
2023
2024
Change
Payables & Accruals
$93,240
$88,967
-5%
Grants Payable
$563,470
$499,428
-11%
Deferred Revenue
$75,000
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
$601,276
$505,776
-16%
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$258,089
$203,971
-21%
Total Liabilities
$1,591,075
$1,298,142
-18%
Net assets
2023
2024
Change
Restricted Net Assets
$2,052,891
$1,975,197
-4%
Unrestricted Net Assets
$2,799,728
$3,149,091
+12%
Net assets
2023
2024
Change
Net assets
+$4,852,619
+$5,124,288
+6%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)